Search Results for: MBOT

Driest Places on Earth

From the frozen landscapes of Antarctica to the scorching deserts of Africa to the often drought-stricken regions of North America, areas that get little to no rainfall tend to have ...
Read Full Story »

Why Wedbush Is Staying Positive on Zafgen

Zafgen Inc. (NASDAQ: ZFGN) shares were absolutely stomped on Monday after the company announced that the U.S. Food and Drug Administration (FDA) had put a clinical hold on its Investigational ...
Read Full Story »

Top Stocks to Look For on July’s FDA Calendar

Biotech and pharmaceutical companies are generally involved in the lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk to a ...
Read Full Story »

How Omeros Won Big on This FDA Approval

Omeros Corp. (NASDAQ: OMER) saw its shares make a handy gain on Tuesday after the company announced that the U.S. Food and Drug Administration (FDA) granted a Breakthrough Therapy designation ...
Read Full Story »

Who Wins From Endo’s Opana Getting Pulled From the Market

In an unprecedented move, the U.S. Food and Drug administration (FDA) requested that Endo International PLC (NASDAQ: ENDP) remove its Opana ER from the market. Ultimately, the agency held concerns ...
Read Full Story »

FDA Shelves Endo Pharma Amid Opioid Abuse

Opioid addiction is a serious problem in the United States and globally, one that spans all demographics. According to a recent study, drug overdose is the leading cause of accidental ...
Read Full Story »

10 Premarket Movers Too Big to Ignore

The broad markets have hit new highs over the past two weeks on the back of a strong earnings season. But over the past few days the markets have been relatively ...
Read Full Story »

No Comeback for Ashley Madison

The Wall Street Journal ran an article about a comeback for adult sex hook-up site Ashley Madison. No matter what plans new management has, the comeback won't happen. Ashley Madison has ...
Read Full Story »
Test tubes

AstraZeneca Gets European Approval for Heart Attack, Gout Treatments

Shares of pharmaceutical giant AstraZeneca PLC (NYSE: AZN) ticked down in Friday’s premarket trading in New York after the company announced that the European Commission (EC) had granted marketing authorization ...
Read Full Story »

What Lit a Fire Under These 3 Pharma Stocks

Over the past week, a few pharmaceutical companies made absolutely massive runs. In the past year, the health care sector was on fire from positive trials, U.S. Food and Drug ...
Read Full Story »

Omeros Shares Doubling on Positive Phase 2 Data

Omeros Corp. (NASDAQ: OMER) is flying high in Tuesday’s trading session with shares practically doubling on positive phase 2 news. The company announced additional positive data in the it’s phase ...
Read Full Story »
health care

ELIQUIS Approved for Deep Vein Thrombosis and Pulmonary Embolisms

Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) announced that the U.S. Food and Drug Administration (FDA) had approved the drug ELIQUIS, as a treatment for Deep Vein Thrombosis and Pulmonary ...
Read Full Story »
Wrigley Field

Will the Chicago Cubs Win the World Series?

You know the story. The Chicago Cubs haven’t won a World Series since 1908, by far the longest championship drought in baseball. So naturally, fans take this to mean their ...
Read Full Story »
Food and Drug Administration logo

FDA Hold on Ariad Kills $2 Billion in Value (Updated)

Ariad Pharmaceuticals Inc. (NASDAQ: ARIA) is getting crushed on Wednesday due to a clinical hold placed by the U.S. Food & Drug Administration. The company confirmed that the FDA has ...
Read Full Story »